Tuesday 26 July 2011

Retavase


Generic Name: retaplase (RE te plase)

Brand Names: Retavase


What is Retavase (retaplase)?

Retaplase is a thrombolytic (THROM-bo-LIT-ik) drug that is used to dissolve blood clots.


Retaplase is used to improve heart function and prevent congestive heart failure or death in people who have had a heart attack.


Retaplase may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Retavase (retaplase)?


You should not receive this medication if you are allergic to retaplase, or if you have a bleeding disorder, a brain tumor or aneurysm, uncontrolled high blood pressure, a history of stroke or blood clots, or recent brain or spinal injury or surgery.

Before using retaplase, tell your doctor if you have kidney or liver disease, eye complications caused by diabetes, an infection of the lining of your heart, or if you have had any recent surgery, injury, or major bleeding.


Tell your doctor if you take aspirin, a blood thinner such as warfarin (Coumadin), or any medications to prevent blood clots, such as abciximab (ReoPro), dipyridamole (Persantine), and others.


Tell your doctor at once if you have a serious side effect such as sudden numbness or weakness, confusion, problems with speech or vision, chest pain, sudden cough, wheezing, rapid breathing, fast or slow heart rate, darkening or purple discoloration of your fingers or toes, blood in your urine or stools, pale skin, easy bruising, or any bleeding that will not stop.

What should I discuss with my health care provider before I receive Retavase (retaplase)?


You should not receive this medication if you are allergic to retaplase, or if you have certain conditions. Be sure your doctor knows if you have:

  • any active bleeding;




  • a bleeding or blood clotting disorder;




  • a brain tumor, aneurysm, or blood vessel disorder;




  • untreated or uncontrolled high blood pressure;




  • a history of stroke or blood clot; or




  • recent spine or brain injury or surgery.



Before you receive retaplase, tell your doctor if you are allergic to any drugs, or if you have:



  • kidney disease;




  • liver disease;




  • eye complications caused by diabetes;




  • an infection of the lining of your heart (also called bacterial endocarditis); or




  • if you have had any recent surgery, injury, or major bleeding.



If you have any of these conditions, you may need a dose adjustment or special tests to safely receive this medicaiton.


FDA pregnancy category C. Retaplase may be harmful to an unborn baby. Before receiving this medication, tell your doctor if you are pregnant. It is not known whether retaplase passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

How is retaplase given?


Retaplase is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting.


Retaplase is usually given in two quick injections through an IV line. These injection are given 30 minutes apart.


This medication can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you have received retaplase.


What happens if I miss a dose?


Since retaplase is given only when needed by a healthcare professional, it is not likely that you will miss a dose.


What happens if I overdose?


An overdose of retaplase is not likely to occur.


What should I avoid after receiving Retavase (retaplase)?


Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using retaplase.


Retavase (retaplase) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Tell your doctor at once if you have a serious side effect such as:

  • sudden numbness or weakness, especially on one side of the body;




  • sudden headache, confusion, problems with vision, speech, or balance;




  • chest pain, sudden cough, wheezing, rapid breathing;




  • fast, slow, or uneven heart rate;




  • feeling like you might pass out;




  • weak pulse, fainting, slow breathing (breathing may stop);




  • darkening or purple discoloration of your fingers or toes;




  • blood in your urine;




  • black, bloody, or tarry stools;




  • coughing up blood or vomit that looks like coffee grounds;




  • bleeding from needle punctures (such as from needles used in blood tests or in giving injection) injections; or




  • pale skin, easy bruising, or any bleeding that will not stop.



Less serious side effects may include:



  • nausea;




  • vomiting; or




  • fever.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Retavase (retaplase)?


The following drugs can interact with retaplase. Tell your doctor if you are using any of these:



  • a blood thinner such as warfarin (Coumadin);




  • aspirin; or




  • medication used to prevent blood clots, such as abciximab (ReoPro), dipyridamole (Persantine), and others.



This list is not complete and there may be other drugs that can interact with retaplase. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Retavase resources


  • Retavase Side Effects (in more detail)
  • Retavase Use in Pregnancy & Breastfeeding
  • Retavase Drug Interactions
  • Retavase Support Group
  • 0 Reviews for Retavase - Add your own review/rating


  • Retavase Prescribing Information (FDA)

  • Retavase Monograph (AHFS DI)

  • Retavase Advanced Consumer (Micromedex) - Includes Dosage Information

  • Retavase MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Retavase with other medications


  • Heart Attack


Where can I get more information?


  • Your doctor or pharmacist can provide more information about retaplase.

See also: Retavase side effects (in more detail)


Monday 18 July 2011

Captopril Tevagen




Captopril Tevagen may be available in the countries listed below.


Ingredient matches for Captopril Tevagen



Captopril

Captopril is reported as an ingredient of Captopril Tevagen in the following countries:


  • Spain

International Drug Name Search

Sunday 17 July 2011

Daewoong Lanfra




Daewoong Lanfra may be available in the countries listed below.


Ingredient matches for Daewoong Lanfra



Lansoprazole

Lansoprazole is reported as an ingredient of Daewoong Lanfra in the following countries:


  • Vietnam

International Drug Name Search

Friday 15 July 2011

Ranitex




Ranitex may be available in the countries listed below.


Ingredient matches for Ranitex



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitex in the following countries:


  • Algeria

International Drug Name Search

Wednesday 13 July 2011

Aclixel




Aclixel may be available in the countries listed below.


Ingredient matches for Aclixel



Paclitaxel

Paclitaxel is reported as an ingredient of Aclixel in the following countries:


  • Mexico

International Drug Name Search

Monday 11 July 2011

Arcrane




Arcrane may be available in the countries listed below.


Ingredient matches for Arcrane



Sodium Alginate

Sodium Alginate is reported as an ingredient of Arcrane in the following countries:


  • Japan

International Drug Name Search

Wednesday 6 July 2011

Becloneb




Becloneb may be available in the countries listed below.


Ingredient matches for Becloneb



Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Becloneb in the following countries:


  • Greece

International Drug Name Search

Nequinate




In some countries, this medicine may only be approved for veterinary use.

Scheme

Prop.INN

CAS registry number (Chemical Abstracts Service)

0013997-19-8

Chemical Formula

C22-H23-N-O4

Molecular Weight

365

Therapeutic Category

Antiprotozoal: Agent against coccidiosis

Chemical Name

3-Quinolinecarboxylic acid, 6-butyl-1,4-dihydro-4-oxo-7-(phenylmethoxy)-, methyl ester

Foreign Names

  • Nequinatum (Latin)
  • Nequinat (German)
  • Néquinate (French)
  • Nequinato (Spanish)

Generic Names

  • Methyl Benzoquate (OS: BAN)
  • Nequinate (OS: USAN)
  • AY 20385 (IS)
  • ICI 55052 (IS)
  • Neoquate (IS)

Brand Name

  • Statyl (veterinary use)
    Virbac, United States

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 5 July 2011

Bronium




Bronium may be available in the countries listed below.


Ingredient matches for Bronium



Bromazepam

Bromazepam is reported as an ingredient of Bronium in the following countries:


  • Bangladesh

International Drug Name Search